Profil
Nikhil Mehta worked as Vice President-Global Regulatory Affairs at Merck & Co., Inc. from 2010 to 2015.
He then worked as Chief Regulatory Strategist & Executive VP at Tang Capital Management LLC.
In 2015, he joined Baxalta, Inc. as Global Head-Regulatory Affairs, where he worked until 2016.
From 2017 to 2019, he worked as Senior VP-Regulatory & Quality Assurance at AVEO Pharmaceuticals, Inc. Dr. Mehta holds a doctorate degree from Rutgers State University of New Jersey.
Ehemalige bekannte Positionen von Nikhil Mehta
| Unternehmen | Position | Ende |
|---|---|---|
| AVEO PHARMACEUTICALS, INC. | General Counsel | 08.10.2019 |
| BAXALTA INC | General Counsel | 01.06.2016 |
| MERCK & CO., INC. | General Counsel | 01.01.2015 |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | General Counsel | - |
Ausbildung von Nikhil Mehta
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Baxalta, Inc.
Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
















